ロード中...
Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients
One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2004
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC344465/ https://ncbi.nlm.nih.gov/pubmed/14766840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.2.707-712.2004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|